Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Addict Med. 2021 Apr 1;15(2):99–108. doi: 10.1097/ADM.0000000000000701

Figure 2.

Figure 2.

Unweighted (left panel) and inverse probability of exposure weighteda (right panel) Kaplan-Meier curves showing the survival experience of patients with receipt of daily and non-daily prescription opioids, 2010-2015.

aIP-weighted curve was adjusted for baseline covariates: age, sex, US census region, index year, Charlson comorbidity index, substance use disorders (alcohol, smoking, opioid overdose), surgical procedure, fracture and strains, pain conditions (headache, neck and jaw pain, back pain, abdominal pain, fibromyalgia), measured at baseline and index periods, and opioid use disorder diagnosis, psychiatric medications (benzodiazepines, antidepressants, gabapentin), number of opioid providers and average daily prescription opioid dose during the index period.